+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transdermal Drug Delivery System Market Research Report by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4896809
  • Report
  • July 2021
  • Region: Global
  • 190 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Transdermal Drug Delivery System Market will Grow to USD 8,424.46 Million by 2026, at a CAGR of 5.54%

FEATURED COMPANIES

  • 3M Company
  • Biogel Technology, Inc.
  • Endo International, Inc.
  • Hisamitsu Pharmaceutical
  • Lavipharm
  • Luye Pharma Group
  • MORE
The Global Transdermal Drug Delivery System Market size was estimated at USD 6,094.33 Million in 2020 and expected to reach USD 6,411.61 Million in 2021, at a Compound Annual Growth Rate (CAGR) 5.54% to reach USD 8,424.46 Million by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Transdermal Drug Delivery System to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Application, the Transdermal Drug Delivery System Market was examined across Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications, Pain Management, and Transdermal Estrogen Therapy.
  • Based on Type, the Transdermal Drug Delivery System Market was examined across Transdermal Patches and Transdermal Semisolids. The Transdermal Patches was further studied across Drug-In-Adhesive Patches, Matrix Patches, Microneedle Patches, and Reservoir Membrane Patches. The Transdermal Semisolids was further studied across Gels, Ointments, and Sprays.
  • Based on End User, the Transdermal Drug Delivery System Market was examined across Home Care Settings and Hospitals & Clinics.
  • Based on Geography, the Transdermal Drug Delivery System Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Transdermal Drug Delivery System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Transdermal Drug Delivery System Market, including 3M Company, 4P Therapeutics, LLC, Biogel Technology, Inc., Boehringer Ingelheim International GmbH, Echo Therapeutics, Inc., Endo International, Inc., Glaxosmithkline PLC, Hisamitsu Pharmaceutical, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Lavipharm, Lead Chemicals Co., Inc., Luye Pharma Group, Mylan N.V., Novartis AG, Noven Pharmaceuticals, Inc., Transdermal Technologies, Inc., and UCB S.A.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Transdermal Drug Delivery System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Transdermal Drug Delivery System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Transdermal Drug Delivery System Market?
4. What is the competitive strategic window for opportunities in the Global Transdermal Drug Delivery System Market?
5. What are the technology trends and regulatory frameworks in the Global Transdermal Drug Delivery System Market?
6. What is the market share of the leading vendors in the Global Transdermal Drug Delivery System Market?
7. What modes and strategic moves are considered suitable for entering the Global Transdermal Drug Delivery System Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3M Company
  • Biogel Technology, Inc.
  • Endo International, Inc.
  • Hisamitsu Pharmaceutical
  • Lavipharm
  • Luye Pharma Group
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. End User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of chronic diseases
5.1.1.2. Rise in geriatric population and upsurge in number of patients suffering from chronic disorders
5.1.1.3. Growing adoption of third-generation transdermal drug delivery systems
5.1.2. Restraints
5.1.2.1. Unsuitable for drugs that irritate or sensitize skin
5.1.3. Opportunities
5.1.3.1. Increasing demand for automated drug delivery systems
5.1.3.2. Demand for novel techniques with low dose and less dosing frequency of drugs
5.1.4. Challenges
5.1.4.1. Under various environmental conditions, adhesions of the system to different skin types result in technical difficulties
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Transdermal Drug Delivery System Market, by Application
6.1. Introduction
6.2. Cardiovascular Diseases
6.3. Central Nervous System Disorders
6.4. Hormonal Applications
6.5. Pain Management
6.6. Transdermal Estrogen Therapy

7. Transdermal Drug Delivery System Market, by Type
7.1. Introduction
7.2. Transdermal Patches
7.2.1. Drug-In-Adhesive Patches
7.2.2. Matrix Patches
7.2.3. Microneedle Patches
7.2.4. Reservoir Membrane Patches
7.3. Transdermal Semisolids
7.3.1. Gels
7.3.2. Ointments
7.3.3. Sprays

8. Transdermal Drug Delivery System Market, by End User
8.1. Introduction
8.2. Home Care Settings
8.3. Hospitals & Clinics

9. Americas Transdermal Drug Delivery System Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Transdermal Drug Delivery System Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Transdermal Drug Delivery System Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. 3M Company
13.2. 4P Therapeutics, LLC
13.3. Biogel Technology, Inc.
13.4. Boehringer Ingelheim International GmbH
13.5. Echo Therapeutics, Inc.
13.6. Endo International, Inc.
13.7. Glaxosmithkline PLC
13.8. Hisamitsu Pharmaceutical
13.9. Hisamitsu Pharmaceutical Co., Inc.
13.10. Johnson & Johnson
13.11. Lavipharm
13.12. Lead Chemicals Co., Inc.
13.13. Luye Pharma Group
13.14. Mylan N.V.
13.15. Novartis AG
13.16. Noven Pharmaceuticals, Inc.
13.17. Transdermal Technologies, Inc.
13.18. UCB S.A.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 3. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 10. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2026
FIGURE 12. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 23. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2026
FIGURE 25. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 31. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, 2018-2026 (USD MILLION)
FIGURE 32. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 33. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, 2018-2026 (USD MILLION)
FIGURE 34. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 35. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2026 (USD MILLION)
FIGURE 36. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 37. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, 2018-2026 (USD MILLION)
FIGURE 38. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 39. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, 2018-2026 (USD MILLION)
FIGURE 40. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 41. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, 2018-2026 (USD MILLION)
FIGURE 42. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 43. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 44. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2026
FIGURE 46. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, 2018-2026 (USD MILLION)
FIGURE 47. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 48. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2026 (USD MILLION)
FIGURE 49. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 50. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 51. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 53. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 54. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 55. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 56. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 57. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 58. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 59. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 61. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 62. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 63. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 64. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 65. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 66. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 67. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 68. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 69. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 70. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 73. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 74. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 75. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 76. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 77. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 78. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 79. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 80. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 81. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 82. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 83. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 84. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 85. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: FPNV POSITIONING MATRIX
FIGURE 86. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 87. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 23. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 24. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 25. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 26. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 27. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 28. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 29. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 30. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 31. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 32. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 33. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 34. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 35. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 36. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 37. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 38. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 39. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 40. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 41. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 42. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 43. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 44. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 45. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 46. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 47. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 48. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 49. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 50. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 51. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 52. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 53. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 54. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 55. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 56. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 57. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 58. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 59. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 60. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 61. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 62. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 63. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 64. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 65. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 66. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 67. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 68. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 69. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 70. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 71. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 72. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 73. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 74. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 75. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 76. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 81. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 82. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 83. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 84. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 85. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 86. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 87. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 88. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 89. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 90. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 91. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 92. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 93. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 94. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 95. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 96. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 97. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 98. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 99. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 100. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 101. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 102. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 103. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 104. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 105. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 106. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 107. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 108. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 109. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 110. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 111. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 112. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 113. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 114. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: SCORES
TABLE 115. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: BUSINESS STRATEGY
TABLE 116. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: PRODUCT SATISFACTION
TABLE 117. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: RANKING
TABLE 118. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 119. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: MERGER & ACQUISITION
TABLE 120. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 121. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 122. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: INVESTMENT & FUNDING
TABLE 123. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 124. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • 3M Company
  • 4P Therapeutics, LLC
  • Biogel Technology, Inc.
  • Boehringer Ingelheim International GmbH
  • Echo Therapeutics, Inc.
  • Endo International, Inc.
  • Glaxosmithkline PLC
  • Hisamitsu Pharmaceutical
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Lavipharm
  • Lead Chemicals Co., Inc.
  • Luye Pharma Group
  • Mylan N.V.
  • Novartis AG
  • Noven Pharmaceuticals, Inc.
  • Transdermal Technologies, Inc.
  • UCB S.A.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll